Maria Cruz Martin Delgado
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Maria Cruz Martin Delgado has a total of 364 co-authors. Here are the top co-authors by number of shared publications:
- Elie Azoulay
Service de médecine intensive et réanimation, Hôpital Saint-Louis, Assistance Publique Des Hôpitaux de Paris, Paris, France
4 shared publications - Marlies Ostermann
Department of Intensive Care, Guy’s & St Thomas’ NHS Foundation Hospital, London, UK
4 shared publications - Alberto Hernández Tejedor
SAMUR-Protección Civil, Madrid, Spain
3 shared publications - Josep Trenado Álvarez
Mutua de Terrassa, Terrassa, Spain
3 shared publications - José Manuel Añón
Department of Critical Care Medicine, Hospital Universitario La Paz, Madrid, Spain
3 shared publications - Laia Fernández-Barat
Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)—Fundació Clínic per la Recerca Biomèdica (FCRB), CibeRes (Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, 06/06/0028), Hospital Clínic de Barcelona, 08036 Barcelona, Spain
3 shared publications
Latest Publications
- 26 October 2026
- Published by Elsevier in Medicina Intensiva (English Edition)
- Vol. 50 (11) , 502631
Perceived sustainability and alternatives to the on-call model in intensive care medicine: A survey of intensivists in the Community of Madrid
- 26 October 2026
- Published by Elsevier in Medicina Intensiva (English Edition)
- Vol. 50 (11) , 502631
Perceived sustainability and alternatives to the on-call model in intensive care medicine: A survey of intensivists in the Community of Madrid
- Open Access
- 12 August 2026
- Published by Springer Nature in Intensive Care Medicine
- Vol. 52 (10) , 2220-2223
Diagnostic errors in critically ill patients: challenges, contributing factors, and improvement strategies through the SEIPS framework
- 12 August 2026
- Published by Springer Nature in Intensive Care Medicine
- Vol. 52 (10) , 2220-2223
Open AccessDiagnostic errors in critically ill patients: challenges, contributing factors, and improvement strategies through the SEIPS framework
- 30 June 2026
- Published by Springer Nature in Intensive Care Medicine
- Vol. 52 (8) , 1765-1768
Family support in intensive care: beyond no effect trials and the hidden challenges of cluster randomization
- 30 June 2026
- Published by Springer Nature in Intensive Care Medicine
- Vol. 52 (8) , 1765-1768
Family support in intensive care: beyond no effect trials and the hidden challenges of cluster randomization
- 24 April 2026
- Published by Elsevier in Medicina Intensiva (English Edition)
- Vol. 50 (6) , 502497
Climate change and sustainability in intensive care medicine
- 24 April 2026
- Published by Elsevier in Medicina Intensiva (English Edition)
- Vol. 50 (6) , 502497
Climate change and sustainability in intensive care medicine
- 24 April 2026
- Published by Elsevier in Medicina Intensiva (English Edition)
- Vol. 50 (8) , 502446
Transforming the management of the critically ill cancer patient: Teamwork, rapid response systems and quality of care
- 24 April 2026
- Published by Elsevier in Medicina Intensiva (English Edition)
- Vol. 50 (8) , 502446
Transforming the management of the critically ill cancer patient: Teamwork, rapid response systems and quality of care
- 9 February 2026
- Published by Springer Nature in Intensive Care Medicine
- Vol. 52 (3) , 574-577
Physiological effects of prone positioning during invasive mechanical ventilation: beyond PaO2
- 9 February 2026
- Published by Springer Nature in Intensive Care Medicine
- Vol. 52 (3) , 574-577
Physiological effects of prone positioning during invasive mechanical ventilation: beyond PaO2
- Open Access
- 25 November 2025
- Published by Springer Nature in Pneumonia
- Vol. 17 (1) , 30
Immunosuppressed patients with COVID-19 pneumonia in ICU: clinical characteristics and factors influencing outcomes
COVID-19 severely impacted global health, especially older adults and those with comorbidities. Immunosuppressed patients are at high risk for severe outco
- 25 November 2025
- Published by Springer Nature in Pneumonia
- Vol. 17 (1) , 30
Open AccessImmunosuppressed patients with COVID-19 pneumonia in ICU: clinical characteristics and factors influencing outcomes
COVID-19 severely impacted global health, especially older adults and those with comorbidities. Immunosuppressed patients are at high risk for severe outco
- Open Access
Recommendations for the use of biomarkers for the management of adults with sepsis: a scoping review and critical appraisal
Objective A synthesis and appraisal of the recommendations for biomarkers in practice guidelines concerning sepsis is required to consolidate evidence-based practice. We generated an evidence gap map (EGM) on the use of biomarkers for managing adults with sepsis. Design Scoping review. Data sources MEDLINE, Guidelines International Network, Pan American Health Organization, Trip Database and UpToDate were searched from 2016 to March 2025. Eligibility criteria Guidance documents (GD) that searched at least one literature source and provided clinical recommendations for the use of biomarkers for the management (diagnosis and prognosis, including treatment response) of adults with sepsis. Data extraction and synthesis Two reviewers independently applied the eligibility criteria and extracted data. We used the AGREE-II (Appraisal of Guidelines for Research and Evaluation) tool to assess the GD quality. GDs that scored ≥50% on the AGREE-II 'Rigour of development' domain were considered robust. We also applied the GRADE (Grading of Recommendations Assessment, Development and Evaluation) system to evaluate if the recommendations were strong or conditional. Results We found 10 GDs, with only half (4/8) having a robust methodology. There were 31 recommendations concerning biomarkers. Among these, 24 (77.4%) recommendations were about single biomarkers, with lactate (23; 74.2%) and procalcitonin (8; 25.8%) most frequently recommended. Biomarker testing focused on prognosis in 28 (90.3%) recommendations. Overall, 16 (51.6%) recommendations were graded strong and 13 (42.0%) were conditional, which we displayed in an EGM. Conclusions The methodology of GDs concerning adult sepsis was poor. Our review calls for more prudent use of biomarkers in specific prognostic scenarios and in combination with standard clinical assessments. Enhancing the methodological quality of future GDs is essential to generate more valid and robust recommendations for optimising patient care.
Open AccessRecommendations for the use of biomarkers for the management of adults with sepsis: a scoping review and critical appraisal
Objective A synthesis and appraisal of the recommendations for biomarkers in practice guidelines concerning sepsis is required to consolidate evidence-based practice. We generated an evidence gap map (EGM) on the use of biomarkers for managing adults with sepsis. Design Scoping review. Data sources MEDLINE, Guidelines International Network, Pan American Health Organization, Trip Database and UpToDate were searched from 2016 to March 2025. Eligibility criteria Guidance documents (GD) that searched at least one literature source and provided clinical recommendations for the use of biomarkers for the management (diagnosis and prognosis, including treatment response) of adults with sepsis. Data extraction and synthesis Two reviewers independently applied the eligibility criteria and extracted data. We used the AGREE-II (Appraisal of Guidelines for Research and Evaluation) tool to assess the GD quality. GDs that scored ≥50% on the AGREE-II 'Rigour of development' domain were considered robust. We also applied the GRADE (Grading of Recommendations Assessment, Development and Evaluation) system to evaluate if the recommendations were strong or conditional. Results We found 10 GDs, with only half (4/8) having a robust methodology. There were 31 recommendations concerning biomarkers. Among these, 24 (77.4%) recommendations were about single biomarkers, with lactate (23; 74.2%) and procalcitonin (8; 25.8%) most frequently recommended. Biomarker testing focused on prognosis in 28 (90.3%) recommendations. Overall, 16 (51.6%) recommendations were graded strong and 13 (42.0%) were conditional, which we displayed in an EGM. Conclusions The methodology of GDs concerning adult sepsis was poor. Our review calls for more prudent use of biomarkers in specific prognostic scenarios and in combination with standard clinical assessments. Enhancing the methodological quality of future GDs is essential to generate more valid and robust recommendations for optimising patient care.
- Open Access
- 24 June 2025
- Published by Springer Nature in Intensive Care Medicine
- Vol. 51 (7) , 1414
Correction: Understanding and mitigating medication errors associated with patient harm in adult intensive care units: a scoping review
- 24 June 2025
- Published by Springer Nature in Intensive Care Medicine
- Vol. 51 (7) , 1414
Open AccessCorrection: Understanding and mitigating medication errors associated with patient harm in adult intensive care units: a scoping review